Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

NCT07502287 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Neuroblastoma
Refractory Neuroblastoma
High-Risk Neuroblastoma
Ganglioneuroblastoma

Interventions

BIOLOGICAL: EB-DTNB-NK
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Beijing Biotech